Anti-TRIM9 antibody [EPR25103-71] - BSA and Azide free
- BOND RX™ Validated
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal TRIM9 antibody. Carrier free. Suitable for IP, IHC-P, WB and reacts with Mouse, Human, Rat samples.
View Alternative Names
KIAA0282, RNF91, TRIM9, E3 ubiquitin-protein ligase TRIM9, RING finger protein 91, RING-type E3 ubiquitin transferase TRIM9, Tripartite motif-containing protein 9
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TRIM9 antibody [EPR25103-71] - BSA and Azide free (AB300516)
This data was developed using ab300515, the same antibody clone in a different buffer formulation.Immunohistochemical analysis of paraffin-embedded Mouse cerebrum tissue labeling TRIM9 with ab300515 at 1/5000 (0.095 ug/ml) followed by a ready to use LeicaDS9800 (Bond Polymer Refine Detection) was used. Positive staining on mouse cerebrum (PMID : 20085810). The section was incubated with ab300515 for 30 mins at room temperature.The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond Polymer Refine Detection) was used.Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TRIM9 antibody [EPR25103-71] - BSA and Azide free (AB300516)
This data was developed using ab300515, the same antibody clone in a different buffer formulation.Immunohistochemical analysis of paraffin-embedded Mouse spleen tissue labeling TRIM9 with ab300515 at 1/5000 (0.095 ug/ml) followed by a ready to use LeicaDS9800 (Bond Polymer Refine Detection) was used. Negative control : no staining on mouse spleen (PMID : 20085810). The section was incubated with ab300515 for 30 mins at room temperature.The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond Polymer Refine Detection) was used.Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TRIM9 antibody [EPR25103-71] - BSA and Azide free (AB300516)
This data was developed using ab300515, the same antibody clone in a different buffer formulation.Immunohistochemical analysis of paraffin-embedded Mouse liver tissue labeling TRIM9 with ab300515 at 1/5000 (0.095 ug/ml) followed by a ready to use LeicaDS9800 (Bond Polymer Refine Detection) was used. Negative control : no staining on mouse liver (PMID : 20085810). The section was incubated with ab300515 for 30 mins at room temperature.The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond Polymer Refine Detection) was used.Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins
- WB
Supplier Data
Western blot - Anti-TRIM9 antibody [EPR25103-71] - BSA and Azide free (AB300516)
This data was developed using ab300515, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration : 5% NFDM/TBST
Negative control : human liver tissue (PMID : 20085810).
The antibody detects isoform of TRIM9 around 61kDa which consistent with what has been described in the literature (PMID : 20085810).
The identity of the lower MW band at approximately 37 kDa (in lane 1, 2) is unknown.
The blot of lane 5 was developed using a high sensitivity ECL substrate.
Exposure time : Lane 1-4 : 136 seconds Lane 5 : 3 minutes
All lanes:
Western blot - Anti-TRIM9 antibody [EPR25103-71] (<a href='/en-us/products/primary-antibodies/trim9-antibody-epr25103-71-ab300515'>ab300515</a>) at 1/1000 dilution
Lane 1:
Human cerebellum tissue lysate at 20 µg
Lane 2:
Human liver tissue lysate at 40 µg
Lane 3:
IMR-32 (human neuroblastoma neuroblast), whole cell lysate at 20 µg
Lane 4:
SK-N-BE(2) (human neuroblastoma neuroblast), whole cell lysate at 20 µg
Lane 5:
Y79 (human retinoblastoma retinoblastoma), whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 79 kDa
Observed band size: 61 kDa,79 kDa
false
- WB
Supplier Data
Western blot - Anti-TRIM9 antibody [EPR25103-71] - BSA and Azide free (AB300516)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The identity of the bands between 37 kDa and 25 kDa are unknown.
Exposure time : Lane 1-5 : 81 seconds Lane 6, 7 : 52 minutes
All lanes:
Western blot - Anti-TRIM9 antibody [EPR25103-71] (<a href='/en-us/products/primary-antibodies/trim9-antibody-epr25103-71-ab300515'>ab300515</a>) at 1/1000 dilution
Lane 1:
Mouse brain tissue lysate at 20 µg
Lane 2:
Mouse hippocampus tissue lysate at 20 µg
Lane 3:
Mouse liver tissue lysate at 40 µg
Lane 4:
Mouse cerebellum tissue lysate at 20 µg
Lane 5:
Rat cerebellum tissue lysate at 20 µg
Lane 6:
Rat brain tissue lysate at 20 µg
Lane 7:
Rat liver tissue lysate at 40 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 79 kDa
Observed band size: 61 kDa,79 kDa
false
- IP
Supplier Data
Immunoprecipitation - Anti-TRIM9 antibody [EPR25103-71] - BSA and Azide free (AB300516)
This data was developed using ab300516, the same antibody clone in a different buffer formulation. TRIM9 was immunoprecipitated from 0.35 mg Mouse brain tissue lysate 10 ug with ab300515 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab300515 at ID188 dilution. VeriBlot for IP secondary antibody (HRP)(ab131366) was used at 1/5000 dilution. Lane 1 : Mouse brain tissue lysate 10 ug Lane 2 : ab300515 IP in Mouse brain tissue lysate Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab300515 in mouse brain tissue lysate. Blocking and dilution buffer and concentration : 5% NFDM/TBST. Exposure time : 41 seconds
Lane 1:
Immunoprecipitation - Anti-TRIM9 antibody [EPR25103-71] (<a href='/en-us/products/primary-antibodies/trim9-antibody-epr25103-71-ab300515'>ab300515</a>) at 1/30 dilution
Lane 2:
Immunoprecipitation - Anti-TRIM9 antibody [EPR25103-71] (<a href='/en-us/products/primary-antibodies/trim9-antibody-epr25103-71-ab300515'>ab300515</a>) at 1/1000 dilution
All lanes:
Mouse brain tissue lysate at 10 µg
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
false
Exposure time: 41s
- IP
Supplier Data
Immunoprecipitation - Anti-TRIM9 antibody [EPR25103-71] - BSA and Azide free (AB300516)
This data was developed using ab300516, the same antibody clone in a different buffer formulation. TRIM9 was immunoprecipitated from 0.35 mg SK-N-BE(2) (human neuroblastoma neuroblast), whole cell lysate 10 ug with ab300515 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab300515 at ID188 dilution. VeriBlot for IP secondary antibody (HRP)(ab131366) was used at 1/5000 dilution. Lane 1 : SK-N-BE(2) (human neuroblastoma neuroblast), whole cell lysate 10 ug Lane 2 : ab300515 IP in SK-N-BE(2) whole cell lysate Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab300515 in SK-N-BE(2) whole cell lysate. Blocking and dilution buffer and concentration : 5% NFDM/TBST. Exposure time : 23 seconds
Lane 1:
Immunoprecipitation - Anti-TRIM9 antibody [EPR25103-71] (<a href='/en-us/products/primary-antibodies/trim9-antibody-epr25103-71-ab300515'>ab300515</a>) at 1/30 dilution
Lane 2:
Immunoprecipitation - Anti-TRIM9 antibody [EPR25103-71] (<a href='/en-us/products/primary-antibodies/trim9-antibody-epr25103-71-ab300515'>ab300515</a>) at 1/1000 dilution
All lanes:
SK-N-BE(2) whole cell lysate at 10 µg
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
false
Exposure time: 23s
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The TRIM9 protein regulates axon pathfinding and synapse formation influencing neural network development. TRIM9 forms complexes with other proteins to modulate cytoskeletal dynamics affecting neuron shape and connectivity. By interacting with proteins like DCC (Deleted in Colorectal Carcinoma) TRIM9 plays a role in guiding axons during neural circuit formation. This interaction is essential for creating proper neuronal connections and ensuring functional communication within the brain.
Pathways
TRIM9 emerges as an important regulator in the Netrin-1 signaling pathway critical for axonal guidance. This pathway involves interaction with DCC a receptor for Netrin-1 influencing axonal steering decisions. Additionally TRIM9 participates in the ubiquitination pathway affecting protein stability and cellular localization that modulates various signaling cascades within neurons. By manipulating these pathways TRIM9 assists in neural development and plasticity.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com